Xuefei Wang

Title: Xuefei Wang: Innovator in Pediatric Leukemia Research

Introduction

Xuefei Wang is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of pediatric oncology, particularly in the area of acute lymphoblastic leukemia (ALL). His work focuses on identifying genetic markers that can help in diagnosing and treating high-risk cases of B-precursor ALL.

Latest Patents

Wang holds a patent titled "Identification of novel subgroups of high-risk pediatric precursor B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same." This invention relates to the identification of genetic markers in patients with high-risk B-precursor acute lymphoblastic leukemia (B-ALL) and explores their relationship to therapeutic outcomes. The patent also encompasses diagnostic and prognostic methods utilizing these genetic markers, along with kits that provide microchips and/or immunoreagents for analyzing leukemia patients. Wang has 1 patent to his name.

Career Highlights

Throughout his career, Xuefei Wang has worked with prominent organizations such as Sandia Corporation and the University of New Mexico. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Wang has collaborated with notable colleagues, including Cheryl L. Willman and Richard Harvey. These partnerships have further enhanced his research and innovation in pediatric leukemia.

Conclusion

Xuefei Wang's contributions to the field of pediatric leukemia research are invaluable. His innovative approaches to identifying genetic markers and developing diagnostic methods have the potential to improve outcomes for children suffering from this challenging disease.